Skip to main content

LCD L34938: Removal of Benign Skin Lesions

LCD L34938, Removal of Benign Skin Lesions, is the Local Coverage Determination that Novitas Solutions, Inc. applies to claims from 11 states plus DC (AR, CO, DC, DE, LA, MD, MS, NJ and others), effective 2019-09-26 and first in force 2015-10-01. The policy text runs 706 words, and its billing and coding article A57113 lists 242 ICD-10-CM codes that support medical necessity for 51 procedure codes. 2 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 242 covered ICD-10-CM codes: 73 fewer codes than L34200 (CGS Administrators, LLC, 315 codes, revised 2026-07-30) and 108 more codes than L35498 (Wisconsin Physicians Service Insurance Corporation, 134 codes, revised 2025-10-30).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Novitas Solutions, Inc.
States and territories
12
AR CO DC DE LA MD MS NJ NM OK PA TX
Revision effective
2019-09-26
Original effective
2015-10-01
Policy text
706 words
Covered ICD-10 codes (articles)
242

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L34938
ContractContractorTypeStates
12101Novitas Solutions, Inc.A and B MACDE
12201Novitas Solutions, Inc.A and B MACDC
12301Novitas Solutions, Inc.A and B MACMD
12401Novitas Solutions, Inc.A and B MACNJ
12501Novitas Solutions, Inc.A and B MACPA
12102Novitas Solutions, Inc.A and B MACDE
12202Novitas Solutions, Inc.A and B MACDC
12302Novitas Solutions, Inc.A and B MACMD
12402Novitas Solutions, Inc.A and B MACNJ
12502Novitas Solutions, Inc.A and B MACPA
12901Novitas Solutions, Inc.A and B MACDC DE MD NJ PA
07102Novitas Solutions, Inc.A and B MACAR
07202Novitas Solutions, Inc.A and B MACLA
07101Novitas Solutions, Inc.A and B MACAR
07201Novitas Solutions, Inc.A and B MACLA
07301Novitas Solutions, Inc.A and B MACMS
07302Novitas Solutions, Inc.A and B MACMS
04111Novitas Solutions, Inc.A and B MACCO
04211Novitas Solutions, Inc.A and B MACNM
04311Novitas Solutions, Inc.A and B MACOK
04411Novitas Solutions, Inc.A and B MACTX
04112Novitas Solutions, Inc.A and B MACCO
04212Novitas Solutions, Inc.A and B MACNM
04312Novitas Solutions, Inc.A and B MACOK
04412Novitas Solutions, Inc.A and B MACTX
04911Novitas Solutions, Inc.A and B MACCO NM OK TX

Billing and coding article A57113: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57113 (Billing and Coding: Removal of Benign Skin Lesions) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A57113: Billing and Coding: Removal of Benign Skin Lesions (Billing and Coding, effective 2026-01-01)

Covered ICD-10-CM codes
242
8 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
51
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A57113
ICD-10-CMDescription (FY2027)
A54.02Gonococcal vulvovaginitis, unspecified
A54.1Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess
A63.0Anogenital (venereal) warts
B07.0Plantar wart
B07.8Other viral warts
B08.1Molluscum contagiosum
C44.00Unspecified malignant neoplasm of skin of lip
C44.01Basal cell carcinoma of skin of lip
C44.02Squamous cell carcinoma of skin of lip
C44.09Other specified malignant neoplasm of skin of lip
C44.1021Unspecified malignant neoplasm of skin of right upper eyelid, including canthus
C44.1022Unspecified malignant neoplasm of skin of right lower eyelid, including canthus
C44.1091Unspecified malignant neoplasm of skin of left upper eyelid, including canthus
C44.1092Unspecified malignant neoplasm of skin of left lower eyelid, including canthus
C44.1121Basal cell carcinoma of skin of right upper eyelid, including canthus
C44.1122Basal cell carcinoma of skin of right lower eyelid, including canthus
C44.1191Basal cell carcinoma of skin of left upper eyelid, including canthus
C44.1192Basal cell carcinoma of skin of left lower eyelid, including canthus
C44.1221Squamous cell carcinoma of skin of right upper eyelid, including canthus
C44.1222Squamous cell carcinoma of skin of right lower eyelid, including canthus
C44.1291Squamous cell carcinoma of skin of left upper eyelid, including canthus
C44.1292Squamous cell carcinoma of skin of left lower eyelid, including canthus
C44.1921Other specified malignant neoplasm of skin of right upper eyelid, including canthus
C44.1922Other specified malignant neoplasm of skin of right lower eyelid, including canthus

Procedure codes: 11200, 11201, 11300, 11301, 11302, 11303, 11305, 11306, 11307, 11308, 11310, 11311, 11312, 11313, 11400, 11401, 11402, 11403, 11404, 11406, 11420, 11421, 11422, 11423, 11424, 11426, 11440, 11441, 11442, 11443, 11444, 11446, 17000, 17003, 17004, 17106, 17107, 17108, 17110, 17111 and 11 more in the article.

Coverage indications, limitations and medical necessity

Notice : Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Benign lesions may be removed in a variety of ways. These methods can be grouped into one of the following three categories.

• Shaving of Epidermal or Dermal Lesions

• Shaving is the sharp removal by transverse incision or horizontal slicing to remove epidermal and dermal lesions without a full-thickness dermal excision. This includes local anesthesia, chemical or electrocauterization. The wound does not require suture closure.

• Excision - Benign Lesions

• Excision of benign lesions of skin includes local anesthesia. Excision is defined as full-thickness (through the dermis) removal of a lesion, including margins, and includes simple (non-layered) closure when performed.

• Destruction, Benign Lesions

• Destruction means the ablation of benign tissues by any method, with or without curettement, including local anesthesia, and not usually requiring closure.

• Medical record documentation must support medical necessity for excisional removal of a benign skin lesion for other than cosmetic purposes. Each benign lesion excised should be reported separately.

Covered Indications

In selected circumstances, the removal of lesions (e.g., seborrheic keratoses, epidermoid cysts, moles [nevi], acquired hyperkeratosis, molluscum contagiosum, milia, viral warts, benign neoplasms, hemangiomas, lipomas, and pyogenic granulomas) is medically appropriate. Therefore, Medicare will consider their removal as medically necessary, and not cosmetic, if one or more of the following conditions are present and clearly documented in the medical record:

• The lesion has become symptomatic or has undergone a change in appearance or displays evidence of inflammation or infection.

• The lesion obstructs an orifice.

• The lesion clinically restricts eye function. For example, the lesion

• restricts eyelid function

• causes misdirection of eyelashes or eyelid

• restricts lacrimal puncta and interferes with tear flow

• touches the globe

• interferes with vision

• There is clinical uncertainty as to the likely diagnosis, particularly where malignancy is a realistic consideration based on lesion appearance or prior biopsy of a related or similar lesion suggesting malignancy.

• A prior histological exam or biopsy suggests or is indicative of atypia (e.g., atypical nevus) or malignancy.

• The lesion is in an anatomical region subject to recurrent physical trauma and there is documentation that such trauma has occurred.

• Removal of molluscum contagiosum.

• Benign epidermal or pilar cyst with history of infection, drainage, or rupture.

• Wart removals will be covered under guidelines above. In addition, wart destruction will be covered when any of the following clinical circumstances are present:

• Periocular warts associated with chronic recurrent conjunctivitis thought to be secondary to lesion virus shedding

• Warts showing evidence of spread from one body area to another

• Lesions are condyloma acuminate

• Please refer to the National Coverage Determination (NCD) 250.4 for coverage details regarding Actinic Keratosis.

Limitations

The following are considered not reasonable and necessary and therefore will be denied:

• Please refer to CMS IOM Publication 100-04, Medicare Claims Processing Manual , Chapter 12, Section 30.6.6 for instructions regarding Evaluation and Management (E/M) services during the global period of surgery and on the same day as a procedure.

• Removal of certain benign skin lesions that do not pose a threat to health or function is considered cosmetic, and as such, is not covered by the Medicare program. If the beneficiary wishes to have one or more of these benign asymptomatic lesions removed for cosmetic purposes, the beneficiary becomes liable for the service rendered. The provider has the responsibility to notify the patient in advance that Medicare will not cover that cosmetic procedure and the beneficiary will be liable for the cost of the service.

• Lesions in sensitive anatomical locations that are not creating problems do not qualify for removal coverage on the basis of location alone.

Notice: Services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.

The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD.

Summary of evidence (opening)

N/A

The contractor cites 3 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2019-09-26
Last reviewed by the contractor
2018-01-29
MCD version
68
Derived from
L27527

The contractor lists one National Coverage Determination as related: NCD 250.4 Treatment of Actinic Keratosis. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Novitas Solutions, Inc. hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L34938 cover?

Benign lesions may be removed in a variety of ways. These methods can be grouped into one of the following three categories. The full 706-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L34938 apply to?

Novitas Solutions, Inc. applies it to Medicare claims in 11 states plus DC: AR, CO, DC, DE, LA, MD, MS, NJ, NM, OK, PA, TX. It binds only that contractor; 2 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L34938?

The companion billing and coding article A57113 lists 242 ICD-10-CM codes in 8 groups that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L34938?

A denial under LCD L34938 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57113's 242 covered diagnosis codes, then file a redetermination with Novitas Solutions, Inc. within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.